Answers are grounded in this paper and cite their sources.
Retrospective observational study evaluates outcomes of ureteroscopic lithotripsy under patient-controlled sedation in patients, suggesting effective safety.
OBJECTIVE: To evaluate the safety, feasibility, and outcomes of ureteroscopic (URS) lithotripsy for distal ureteral stones under patient-controlled sedation (PCS) in a large single-center cohort. METHODS: This retrospective observational study included 414 patients who underwent 429 URS lithotripsies under intravenous PCS with propofol and alfentanil between 2017 and 2023. Pre-, peri-, and postoperative variables were assessed, and outcomes were analyzed according to stone-free status using graded definitions. Grade A indicated complete stone-free status with no residual stones on postoperative CT, Grade B included Grade A with residual fragments ≤2 mm, and Grade C included Grades A and B with residual fragments measuring 2.1-4 mm. RESULTS: = 414; Grade C). The rate of complications (Clavien-Dindo ≥III) was 1%, and no adverse events occurred. The procedure was aborted in 1% of cases, and 99% of procedures were completed on an outpatient basis without anesthesiology support. Non-stone-free patients (5%) more frequently had multiple or larger stones and a history of stone disease, although no associations were identified with sedation volume or surgeon experience. CONCLUSION: URS lithotripsy under PCS is safe and effective for distal ureteral stones, with a high stone-free rate and low complication rate, and may offer practical advantages in clinical practice.
No takes yet. Share an insight, caveat, or question.
Je et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: